Autonomix (AMIX) Medical announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Brad Hauser, CEO of Autonomix, elaborates on the Company’s recently announced planned follow-on market expansion study phase of its proof-of-concept trial.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMIX:
- Autonomix announces first patient enrolled, treated in follow-on phase to POC 2
- Autonomix granted U.S. patent for catheter-based platform technology
- Autonomix granted approval to expand PoC human clinical trial
- Autonomix granted key U.S. patent for catheter-based platform technology
- Autonomix CEO outlines follow-on expansion study expected to begin in Q2